REQUEST A DEMO
Total
USD $0.00
Search more companies

Ultimed Scientific Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Ambulatory Health Care Services
Full name: Ultimed Scientific Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ultimed Scientific Sdn. Bhd. is a company based in Malaysia, with its head office in Cheras. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 08, 2013. There was a net sales revenue increase of 46.78% reported in Ultimed Scientific Sdn. Bhd.’s latest financial highlights for 2022. Over the same period, its total assets grew by 29.7%. In 2022, Ultimed Scientific Sdn. Bhd.’s net profit margin increased by 0.84%.

Headquarters
No B-15-1, Jalan C180/1, Dataran C180
Cheras; Selangor; Postal Code: 43200

Contact Details: Purchase the Ultimed Scientific Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ultimed Scientific Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Ultimed Scientific Sdn. Bhd. report to view the information.
Incorporation Date:
January 08, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Ultimed Scientific Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
46.78%
Total operating revenue
46.78%
Operating profit (EBIT)
149.54%
Net Profit (Loss) for the Period
285.55%
Total assets
29.7%
Total equity
18.38%
Operating Profit Margin (ROS)
0.82%
Net Profit Margin
0.84%
Return on Equity (ROE)
10.76%
Debt to Equity Ratio
40.45%
Quick Ratio
-0.4%
Cash Ratio
-0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?